Page 24 - Ovarian Cancer Surgery - Quality Indicators
P. 24
Original studies evaluating the impact of physician specialty on survival continued
Authorreference Year FIGO Specialties N Survival analysis
HR 95% CI
stage p-value Type of analysis
Disease-free survival 2009 I-IV GYO reference vs. GYN 98 vs. 136 0.861 0.573-1.295 0.473 multivariate
Kumpulainen et al.178 GYO reference vs. GYN 102 vs. 136
5-year ovarian cancer specific mortality
Kumpulainen et al.178 2009 I-IV 1.237 0.752-2.03 0.403 multivariate
CI confidence interval, GYO gynecologic oncologist, GYN general gynecologist, HR hazard ratio.
Table 8. Original studies evaluating the impact of physician specialty on surgical outcome
Authorreference Year FIGO Specialties N Survival analysis
stage
HR 95% CI p-value Type of analysis
No residual tumour 2006 III OB/GYN reference vs. GYO 142 vs. 98 2.45 1.20-5.01 0.014 univariate
2006 III OB/GYN reference vs. GYO 92 vs. 53 3.40 1.51-7.65 0.003 univariate
Engelen et al.233,a,b,c 2006 IIIC OB/GYN reference vs. GS 99 vs. 24 1.17 0.41, 3.30 0.771 univariate
Kumpulainen et al.236,a,b,d 2006 IIIC OB/GYN reference vs. GYO 99 vs. 75 1.19 0.59-2.40 0.632 univariate
Paulsen et al.237,a,b,d 2007 III-IV OB/GYN reference vs. GS 233 vs. 46 0.14 0.00-0.83 0.026 univariate
Paulsen et al.237,a,b,d 2007 III-IV OB/GYN reference vs. GYO 233 vs. 137 1.12 0.56-2.23 0.742 univariate
Skirnisdottir et al.239,a,c
Skirnisdottir et al.239,a,c
Residual tumour ≤ 1 mm 1992 IIIC-IVA Other reference vs. GYO 137 vs. 126 10.86 6.06-19.45 < 0.001 univariate
Eisenkop et al.241,a,c
Residual tumour ≤ 2 mm 1992 IIB-IV OB/GYN reference vs. GS 14 vs. 13 0.06 0.01-0.62 0.018 univariate
2006 III OB/GYN reference vs. GYO 92 vs. 53 1.36 0.69-2.69 0.373 univariate
Grant et al.245,a,c
Kumpulainen et al.236,a,b,d
Residual tumour < 20 mm 1999 III OB/GYN reference vs. GS 432 vs. 146 0.33 0.19-0.57 < 0.001 univariate
2006 III OB/GYN reference vs. GYO 277 vs. 163 1.30 0.87-1.93 0.198 univariate
Junor et al.229,a,b,c 2001 III-IV OB/GYN reference vs. GS 148 vs. 5 0.30 0.03-2.77 0.290 univariate
Engelen et al.233,a,b,c 2002 III-IV OB/GYN reference vs. GS 65 vs. 44 0.41 0.16-1.02 0.055 univariate
Olaitan et al.224,a,b,d 2007 III-IV OB/GYN reference vs. GS 233 vs. 46 0.12 0.03-0.50 0.004 univariate
Grossi et al.231,a,b,c 2007 III-IV OB/GYN reference vs. GYO 233 vs. 137 1.44 0.92-2.26 0.114 univariate
Skirnisdottir et al.239,a,c
Skirnisdottir et al.239,a,c
Debulking > 95 % and residual tumour < 15 mm
Chen et al.244,a,c 1985 III-IV OB/GYN ref erence vs. GYO 37 vs. 47 75.57 9.35-610.74 < 0.001 univariate
a study included in the systematic review published by du Bois et al. 2009) 209, b study included in the systematic review published by Vernooij et al. 2007) 228, c
retrospective study, d prospective study, CI confidence interval, GS general surgeon, GYO gynecologic oncologist, HR hazard ratio, OB/GYN obstetrician/general
gynecologist, NA data not available.
OVARIAN CANCER SURGERY - QUALITY INDICATORS
24
